Cell therapy for Parkinson's disease

New England Journal of Medicine

Volumn 344, Issue 10, 2001, Pages 763-765

  Fischbach, G D ^a   McKhann, G M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADOPTIVE IMMUNOTHERAPY; CELL TRANSPLANTATION; CLINICAL FEATURE; DOPAMINERGIC NERVE CELL; DYSKINESIA; EDITORIAL; HUMAN; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL APPROACH/SOURCE; CONTROL GROUPS; PROFESSIONAL PATIENT RELATIONSHIP;

BRAIN TISSUE TRANSPLANTATION; CELL LINE; CONTROL GROUPS; CONTROLLED CLINICAL TRIALS; DOPAMINE; FETAL TISSUE TRANSPLANTATION; HUMANS; MESENCEPHALON; NEURONS; PARKINSON DISEASE; RESEARCH DESIGN;

EID: 0035826099     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200103083441011     Document Type: Editorial

References (9)

1. Parkinson's disease
2. New developments in understanding the etiology of Parkinson's disease and in its treatment
3. Fetal tissue transplantation in Parkinson's disease
4. Transplantation of embryonic dopamine neurons for severe Parkinson's disease
5. The ethical problems with sham surgery in clinical research
6. Functional and pathophysiological models of the basal ganglia
7. The search for neural progenitor cells: Prospects for the therapy of neurodegenerative disease
8. The human pluripotent stem cell: Impact on medicine and society
9. Cell replacement therapies For central nervous system disorders